XML 95 R27.htm IDEA: XBRL DOCUMENT
v3.24.0.1

MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Schedule of Revenues Recognized under Agreement | Revenues recognized under the agreement were as follows (in thousands):
| Year Ended December 31,
| 2023 |  | 2022 |  | 2021 |  |  |
Revenue related to Kite agreement: |  |  |  |  |  |  |  |
Recognition of license fee fixed consideration | $ | 19,423 |  |  | $ | 37,032 |  |  | $ | 24,977 |  |  |  |
Research services variable consideration | 1,097 |  |  | 1,560 |  |  | 476 |  |  |  |
Total | $ | 20,520 |  |  | $ | 38,592 |  |  | $ | 25,453 |  |  |  |
Revenues recognized under the agreement were as follows (in thousands):
| Year Ended December 31,
| 2023 |  | 2022 |  | 2021 |  |  |
Revenue related to Novartis agreement: |  |  |  |  |  |  |  |
Recognition of upfront license fee | $ | 9,568 |  |  | $ | 31,344 |  |  | $ | 29,945 |  |  |  |
Research services | 2,611 |  |  | 8,384 |  |  | 7,999 |  |  |  |
Total | $ | 12,179 |  |  | $ | 39,728 |  |  | $ | 37,944 |  |  |  |
Revenues recognized under the agreement were as follows (in thousands):
| Year Ended December 31,
| 2023 |  | 2022 |  | 2021 |  |  |
Revenue related to Biogen agreement: |  |  |  |  |  |  |  |
Recognition of license and other fixed consideration | $ | 132,165 |  |  | $ | 21,820 |  |  | $ | 29,224 |  |  |  |
Cost-sharing payments for research services, net variable consideration | 2,684 |  |  | 6,599 |  |  | 13,076 |  |  |  |
Total | $ | 134,849 |  |  | $ | 28,419 |  |  | $ | 42,300 |  |  |  |
Revenues recognized under the agreement were as follows (in thousands):
| Year Ended December 31,
| 2023 |  | 2022 |  | 2021
Revenue related to Sanofi agreement: |  |  |  |  |
Recognition of upfront fee | $ | — |  |  | $ | 677 |  |  | $ | 34 |
Research services | — |  |  | 2,126 |  |  | 3,057 |
Milestone achievement | — |  |  | 457 |  |  | 23 |
Total | $ | — |  |  | $ | 3,260 |  |  | $ | 3,114 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration